Cochlear

Cochlear Shares Outstanding

The The number of shares of Cochlear (COH.AX) as of Oct 23, 2026 is 65.61 M. In the previous year, The number of shares was 65.61 M — a change of 0.00% (lower).

Shares Outstanding

65.61 M

YoY

0.00%

Last updated:

In 2026, Cochlear had 65.61 M outstanding stocks, a 0.00% change from the 65.61 M stocks in the previous year.

The Cochlear Shares Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Shares Outstanding
Date
Shares Outstanding
Jan 1, 2024
65.61 M AUD
Jan 1, 2025
65.61 M AUD
Jan 1, 2026
65.61 M AUD
Jan 1, 2027 (e)
65.40 AUD
Jan 1, 2028 (e)
65.40 AUD
Jan 1, 2029 (e)
65.40 AUD
Jan 1, 2030 (e)
65.40 AUD
Jan 1, 2031 (e)
65.40 AUD
The Cochlear Shares Outstanding history
YEARShares OutstandingYoY
est65.400.00%
est65.400.00%
est65.400.00%
est65.400.00%
est65.40-100.00%
65.61 M0.00%
65.61 M0.00%
65.61 M0.00%
65.61 M0.00%
65.61 M0.00%
65.61 M0.00%
65.61 M0.00%
65.61 M0.00%
65.61 M0.00%
65.61 M0.00%
65.61 M0.00%
65.61 M0.00%
65.61 M+115.00 M%
57.05+0.01%
57.04+0.22%
56.92-0.11%
56.98+0.70%
56.58+1.08%
55.98+0.36%
55.78—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cochlear Number of shares

Cochlear shares outstanding

The number of shares of Cochlear was 65.54 M in 2025. This indicates how many shares Cochlear is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2024
65.62 M Stocks
Jan 1, 2025
65.54 M Stocks
Jan 1, 2026
65.40 M Stocks
Jan 1, 2027 (e)
65.40 M Stocks
Jan 1, 2028 (e)
65.40 M Stocks
Jan 1, 2029 (e)
65.40 M Stocks
Jan 1, 2030 (e)
65.40 M Stocks
Jan 1, 2031 (e)
65.40 M Stocks

Cochlear Stock analysis

What does Cochlear do? Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear is one of the most popular companies on Eulerpool.

Shares Outstanding Details

Evaluating Cochlear's Shares Outstanding

Cochlear's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Cochlear’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Cochlear’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Cochlear’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Cochlear stock

The number of shares of Cochlear is 65.61 M in 2026.

The number of shares of Cochlear changed from 65.61 M to 65.61 M, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The number of shares Cochlear since 2006 – with annual values, charts, and detailed analysis.

The number of shares indicates the total number of a company's shares. This includes not only the shares available on the market, but also the shares held by shareholders and the shares retained by the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Other — Cochlear

Shares OutstandingSupply ChainNet Debt per ShareAssets per Share

All Key Metrics — Cochlear